Herpes simplex virus type 1 amplicon vectors with glucocorticoid-inducible gene expression.
about
Reduced pathology and improved behavioral performance in Alzheimer's disease mice vaccinated with HSV amplicons expressing amyloid-beta and interleukin-4.Genetic analysis of the role of protein kinase C signaling pathways in behaviors by direct gene transfer with HSV-1 vectors.Promoter-activated expression of nerve growth factor for treatment of neurodegenerative diseases.Gene therapy in the CNS.Expression of human immunodeficiency virus type 1 gp120 from herpes simplex virus type 1-derived amplicons results in potent, specific, and durable cellular and humoral immune responses.Neuroprotective potential of a viral vector system induced by a neurological insult.Use of suicide genes for cancer gene therapy: study of the different approaches.Gene transfer into hepatocytes mediated by helper virus-free HSV/AAV hybrid vectorsHSV-1 amplicon vectors: a promising and versatile tool for gene delivery.Prevention of hepatic tumor metastases in rats with herpes viral vaccines and gamma-interferon.HSV-1-derived amplicon vectors: recent technological improvements and remaining difficulties--a review.Hexamethylene bisacetamide leads to reduced helper virus-free HSV-1 amplicon expression titers via suppression of ICP0.Herpes Virus Amplicon Vectors.Expression of vhs and VP16 during HSV-1 helper virus-free amplicon packaging enhances titers.Effects of ex vivo transduction of mesencephalic reaggregates with bcl-2 on grafted dopamine neuron survivalTargeted transgene integration into transgenic mouse fibroblasts carrying the full-length human AAVS1 locus mediated by HSV/AAV rep(+) hybrid amplicon vector.HSV-1 infected cell proteins influence tetracycline-regulated transgene expression.
P2860
Q30482492-09CB0439-121C-486E-BF03-397F4F0A9C16Q33651647-69ADB436-F794-4600-B01B-040D9D68C136Q33749480-857EA4E2-6411-468C-9E3B-5448205DDA57Q33837123-1EEA837B-CC8C-4959-A965-E3A1487BC795Q34363528-D10EFCE9-BB90-4B34-9ABB-9296460B6390Q35202981-5B9588FD-2077-4A59-B888-A277181785E1Q35753524-F2ADDE4C-A47C-4684-B41F-385532B9767DQ36438166-B516A76C-BCE5-43F3-8049-BE802724D7B1Q36897379-7FBFFE04-DF1E-40F2-A6F7-AA5EF9C9187EQ37363640-D65A5762-F1CD-4FB7-8C0D-C2A18202D912Q37528088-8342148F-3AF1-4F80-A125-3AD7CE501AD0Q39601616-4105771A-D280-43C4-B9E4-200357F93234Q39923388-FB20DB27-DB94-4CBE-9376-1BE1ED14CFCEQ40811145-868ECAA9-DB7F-4483-860C-BC010D6199F7Q42617926-26157F30-5347-4CE9-90B9-CDECE9E815CDQ45864772-95B15B66-E2DF-4005-8FC6-07139D14F6EDQ52541335-316E1D64-63A8-43F3-A08D-30A7362BA8E7
P2860
Herpes simplex virus type 1 amplicon vectors with glucocorticoid-inducible gene expression.
description
1995 nî lūn-bûn
@nan
1995年の論文
@ja
1995年論文
@yue
1995年論文
@zh-hant
1995年論文
@zh-hk
1995年論文
@zh-mo
1995年論文
@zh-tw
1995年论文
@wuu
1995年论文
@zh
1995年论文
@zh-cn
name
Herpes simplex virus type 1 am ...... oid-inducible gene expression.
@en
type
label
Herpes simplex virus type 1 am ...... oid-inducible gene expression.
@en
prefLabel
Herpes simplex virus type 1 am ...... oid-inducible gene expression.
@en
P356
P1433
P1476
Herpes simplex virus type 1 am ...... oid-inducible gene expression.
@en
P2093
P304
P356
10.1089/HUM.1995.6.4-419
P577
1995-04-01T00:00:00Z